| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT07448155 A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989… |
date change Primary completion pushed: 2026-05-23 -> 2026-10-19 |
| 2026-06-09 | NCT07448155 A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989… |
date change Completion pushed: 2026-05-23 -> 2026-10-19 |
| 2026-05-29 | NCT06516952 A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-27 | NCT06585774 A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic… |
Trial sites expanded: 119 -> 122 locations |
| 2026-05-27 | NCT07214779 Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants… |
Trial sites expanded: 162 -> 165 locations |
| 2026-05-27 | NCT07023627 A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin… |
Trial sites reduced: 82 -> 79 locations |
| 2026-05-23 | NCT06388564 A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib… |
overall status: "Recruiting" → "Active Not Recruiting" |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-03 | NCT07623200 A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With… | Phase 3 | Not Yet Recruiting |
| 2026-05-14 | NCT07588139 A Study to Evaluate Dermal Open-Flow Microperfusion and Plasma Pharmacokinetic Study of… | Phase 1 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06958211 | Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With… | Hidradenitis Suppurativa | Recruiting |
| NCT06959225 | Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With… | Hidradenitis Suppurativa | Recruiting |
| NCT06615050 | A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant… | Graft-versus-host Disease (GVHD) | Recruiting |
| NCT06585774 | A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic… | Chronic Graft-versus-host-disease | Recruiting |
| NCT06855498 | Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib | Hidradenitis Suppurativa (HS) | Recruiting |
| NCT07214779 | Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants… | Ovarian Cancer | Recruiting |
| NCT07284849 | A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and… | CRC (Colorectal Cancer) | Recruiting |
| NCT07522073 | A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS… | Solid Tumors | Recruiting |
| NCT06263478 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy… | Chronic Graft-versus-host-disease | Active, Not Recruiting |
| NCT06113445 | A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental… | NonSegmental Vitiligo | Active, Not Recruiting |
| NCT06212999 | A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants… | Hidradenitis Suppurativa (HS) | Active, Not Recruiting |
| NCT06821542 | A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic… | Chronic Graft-versus-host-disease | Active, Not Recruiting |
| NCT04205812 | Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small… | Metastatic Squamous Non-Small Cell Lung Cancer | Active, Not Recruiting |
| NCT06113471 | A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental… | NonSegmental Vitiligo | Active, Not Recruiting |
| NCT04824092 | Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate… | Diffuse Large B-cell Lymphoma | Active, Not Recruiting |
| NCT06516965 | A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With… | Prurigo Nodularis | Active, Not Recruiting |
| NCT05429268 | Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in… | Large B-Cell Lymphoma | Active, Not Recruiting |
| NCT06516952 | A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With… | Prurigo Nodularis | Active, Not Recruiting |
| NCT07623200 | A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With… | Essential Thrombocythemia | Not Yet Recruiting |
| Phase 2 | |||
| NCT05851443 | A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With… | Moderate to Severe Asthma | Recruiting |
| NCT05090891 | To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With… | Fibrodysplasia Ossificans Progressiva (FOP) | Recruiting |
| NCT07213973 | Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With… | Hidradenitis Suppurativa (HS) | Recruiting |
| NCT07023627 | A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin… | Ovarian Cancer | Recruiting |
| NCT07104565 | Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With… | Immune Thrombocytopenia | Recruiting |
| NCT07124078 | A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants… | Chronic Graft-versus-host-disease | Recruiting |